Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis

被引:31
|
作者
Noyan, Aytul [1 ]
Parmaksiz, Gonul [1 ]
Dursun, Hasan [1 ]
Ezer, Semire Serin [1 ]
Anarat, Ruksan [1 ]
Cengiz, Nurcan [1 ]
机构
[1] Baskent Univ, Adana Teaching & Res Hosp, Pediat Nephrol, Pediat Surg,Biochem, Adana, Turkey
关键词
Antenatal hydronephrosis; Kidney injury molecule-1; Liver-type fatty acid-binding proteins; Neutrophil gelatinase-associated lipocalin; Renal injury; GELATINASE-ASSOCIATED LIPOCALIN; INJURY MOLECULE-1 KIM-1; KIDNEY INJURY; BIOMARKER;
D O I
10.1016/j.jpurol.2015.02.021
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction The clinical tests currently in use for obstructive nephropathy (such as renal ultrasonography, differential radionuclide renal scans and urinary creatinine concentration data) are not efficient predictors of the subsequent clinical course. Novel and simple biomarkers are required which, if proven, could be clinically beneficial in determining if a patient is eligible for surgery or reno-protective therapy. More recently, the interest of clinicians has focused on the potential of urinary neutrophil gelatinase-associated lipocalin (uNGAL), urinary kidney injury molecule-1 (uKIM-1) and urinary liver-type fatty acid-binding proteins (uL-FABP) as biomarkers for renal function in children with hydronephrosis (HN). Objective The purpose of this study was to investigate possible clinical applications of uNGAL, uKIM-1 and uL-FABP as beneficial non-invasive biomarkers to determine whether or not surgical intervention is required in children with HN. Study design Renal ultrasonography and radionuclide renal scans were used as diagnostic tools to detect HN. Patients were divided into two groups based on the anteroposterior diameter of their renal pelvis and the presence of dysfunction. Group 1 included 26 children with severe HN (with dysfunction), and group 2 consisted of 36 children with mild HN (without dysfunction). Urine samples were collected from 62 children with HN and 20 healthy children. Results Hydronephrosis was more common in males than in females, with a male to female ratio of 9: 1 in the study sample. The incidence of left kidney involvement (32 patients) was slightly higher than right kidney involvement (28 patients). Compared with controls and group 2, the ratio of uNGAL to creatinine was significantly higher in group 1 (p < 0.05). The biomarker uNGAL/Cr exhibited fairly good diagnostic accuracy, with an area under the curve of 0.68 [95% confidence interval 0.6-0.7] and an optimal cut-off value of 0.16 ng/mg Cr (sensitivity 58%, specificity 75%) (p < 0.05). There was a positive correlation between the uNGAL/Cr ratio and the uKIM-1/Cr ratio (r = 0.582, p < 0.05) and uL-FABP/Cr ratio (r = 0675, p < 0.05) in group 1. Discussion The results clearly demonstrated that children with hydronephrosis and dysfunction had significantly increased uNGAL, and uNGAL/Cr concentrations. However, uKIM-1, uKIM-1/Cr, uL-FABP and uL-FABP/Cr concentrations were not significantly different when compared with controls. These results support the use of uNGAL concentrations as an early marker for renal dysfunction in HN. Conclusions The study clearly demonstrated that pediatric patients with hydronephrosis and dysfunction had significantly higher uNGAL to creatinine concentrations as compared with controls.
引用
收藏
页码:249.e1 / 249.e6
页数:6
相关论文
共 50 条
  • [1] Urinary Ngal, Kim-1 And L-fabp Levels In Antenatal Hydronephrosis
    Dursun, Hasan
    Noyan, Aytul
    Parmaksiz, Gonul
    Ezer, Semire Serin
    Anarat, Ruksan
    Cengiz, Nurcan
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1701 - 1701
  • [2] Urinary Ngal, Kim-1 And L-fabp Levels In Patients With Vesicoureteral Reflux
    Parmaksiz, Gonul
    Noyan, Aytul
    Dursun, Hasan
    Ince, Emine
    Anarat, Ruksan
    Cengiz, Nurcan
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1701 - 1701
  • [3] NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction
    Holzscheiter, Leon
    Beck, Claus
    Rutz, Sandra
    Manuilova, Ekaterina
    Domke, Ingrid
    Guder, Walter G.
    Hofmann, Walter
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (04) : 537 - 546
  • [4] The Value of Urinary L-FABP, KIM-1, NGAL and Serrum Cystatin C in Predicting the Early Diabetic Nephropathy
    Xu, Yong
    Yang, Maojun
    Zhou, Xueqin
    Huang, Wei
    Xie, Fei
    Gao, Chenlin
    DIABETES, 2013, 62 : A607 - A607
  • [5] Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP
    Gönül Parmaksız
    Aytül Noyan
    Hasan Dursun
    Emine İnce
    Rüksan Anarat
    Nurcan Cengiz
    Pediatric Nephrology, 2016, 31 : 97 - 103
  • [6] Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP
    Parmaksiz, Gonul
    Noyan, Aytul
    Dursun, Hasan
    Ince, Emine
    Anarat, Ruksan
    Cengiz, Nurcan
    PEDIATRIC NEPHROLOGY, 2016, 31 (01) : 97 - 103
  • [7] Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography
    Isidro Torregrosa
    Carmina Montoliu
    Amparo Urios
    María Jesús Andrés-Costa
    Carla Giménez-Garzó
    Isabel Juan
    María Jesús Puchades
    María Luisa Blasco
    Arturo Carratalá
    Rafael Sanjuán
    Alfonso Miguel
    Heart and Vessels, 2015, 30 : 703 - 711
  • [8] Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography
    Torregrosa, Isidro
    Montoliu, Carmina
    Urios, Amparo
    Jesus Andres-Costa, Maria
    Gimenez-Garzo, Carla
    Juan, Isabel
    Jesus Puchades, Maria
    Luisa Blasco, Maria
    Carratala, Arturo
    Sanjuan, Rafael
    Miguel, Alfonso
    HEART AND VESSELS, 2015, 30 (06) : 703 - 711
  • [9] L-FABP and KIM-1 New Urinary Biomarkers of Kidney Function in Heart Allograft Recipients
    Malyszko, J.
    Przybylowski, P.
    Malyszko, J.
    Koc-Zorawska, E.
    Mysliwiec, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 476 - 476
  • [10] 尿KIM-1、NGAL、L-FABP与早期糖尿病肾病研究现状
    杨茂君
    徐勇
    国际泌尿系统杂志, 2012, (04) : 567 - 571